Development

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

Researchers continue efforts to overcome challenges of effective oral delivery of biologic drugs.

Seeking Solutions for Oral Delivery of Biologic APIs

Effective solutions for overcoming the high molecular weight, hydrophilicity, and instability of large biomolecules have yet to be identified.

Oral Delivery of Biologic APIs: The Challenge Continues

The investment will be used to advance Nemaura’s R&D programs, which include liquid vaccines that have been reformulated for administration through the skin using its micropatch drug delivery technology.

Nemaura Pharma Receives Funding to Develop Biologic Micropatch System

A variety of strategies have been employed to deliver proteins and peptides in improved parenteral formulations and/or via noninvasive routes.

Advances in Delivering Protein and Peptide Therapeutics

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Aseptic spray drying provides an alternative to lyophilization as an enabling stabilization technology for parenteral biologic formulations.

Exploring the Use of Aseptic Spray Drying in the Manufacture of Biopharmaceutical Injectables

The collaboration will focus on development of novel molecules using SMARTag technology to couple different therapeutic modalities.

Catalent Biologics and Roche Announce Research Collaboration

BioOutsource releases informational video detailing issues associated with ADCC assays and how to effectively analyze them.

BioOutsource Releases Video Addressing Issues with using ADCC Assays

Catalent’s SMARTag™ technology enables biologic innovators to develop more efficacious antibody drug conjugates. It allows site-specific, programmable drug placement using proprietary cytotoxin-linkers/conjugation chemistry in an efficient and scalable process.

Site-Specific ADC Generation Using SMARTag™ Technology

The development of successful ADCs involves careful selection of drug, antibody, and linker, as well as choosing the right attachment chemistry to link the cytotoxic to the antibody.

Building Safe and Effective Antibody-Drug Conjugates

Ananda Seneviratne is principal scientist, Analytical and Formulation Development at Agensys, Inc., Santa Monica, CA.

Gaya Ratnaswamy is director, Analytical and Formulation Development at Agensys, Inc., Santa Monica, CA.

Formulation and Drug Delivery, Biologic Drugs